Predictors of successful cardioversion of recent-onset atrial fibrillation to sinus rhythm with orally inhaled flecainide

被引：0

作者：

Ruskin, J. ^{[1
]}

Dufton, C. ^{[2
]}

Maupas, J. ^{[2
]}

Crijns, H. ^{[3
]}

Elvan, A. ^{[4
]}

De Jong, J. ^{[5
]}

Oosterhof, T. ^{[6
]}

Tuininga, Y. ^{[7
]}

Badings, E. ^{[7
]}

Aksoy, I ^{[8
]}

Nuyens, D. ^{[9
]}

Van Dijk, V. ^{[10
]}

Camm, A. J. ^{[11
]}

Kowey, P. ^{[12
]}

Belardinelli, L. ^{[2
]}

机构：

[1] Mass Gen Hop MGH, Boston, MA USA

[2] InCarda Therapeut, Newark, CA USA

[3] Maastricht Univ, Med Ctr MUMC, Maastricht, Netherlands

[4] Isala Clin, Zwolle, Netherlands

[5] Hosp Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands

[6] Gelderse Vallei Hosp, Ede, Netherlands

[7] Deventer Hosp, Deventer, Netherlands

[8] Admiraal Ruijter Hosp, Goes, Netherlands

[9] Hosp Oost Limburg ZOL, Genk, Belgium

[10] St Antonius Hosp, Nieuwegein, Netherlands

[11] St Georges Univ London, London, England

[12] Lankenau Heart Inst, Wynnewood, PA USA

来源：

EUROPEAN HEART JOURNAL | 2022年 / 43卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：440 / 440

页数：1

共 50 条

[1] The Safety of Pharmacological Cardioversion of Recent Onset Atrial Fibrillation with Orally Inhaled Flecainide
Dufton, Christopher
Maupas, Jean
Ruskin, Jeremy
Crijns, Harry
Belardinelli, Luiz
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2022, 33 (04) : 800 - 801
[2] REVERSION OF RECENT-ONSET ATRIAL-FIBRILLATION TO SINUS RHYTHM BY INTRAVENOUS FLECAINIDE
DONOVAN, KD
DOBB, GJ
COOMBS, LJ
LEE, KY
WEEKES, JN
MURDOCK, CJ
CLARKE, GM
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (02): : 137 - 141
[3] Predictors of Successful Cardioversion with Vernakalant in Patients with Recent-Onset Atrial Fibrillation
Mochalina, Natalia
Juhlin, Tord
Ohlin, Bertil
Carlson, Jonas
Holmqvist, Fredrik
Platonov, Pyotr G.
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2015, 20 (02) : 140 - 147
[4] Orally Inhaled Flecainide for the Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm: Final Results From the Phase 2 Instant Trial
Camm, Alan J.
Crijns, Harry
Elvan, Arif
Tuininga, Ype
Badings, Erik
Kuijper, Aaf
de Jong, Jonas
Lee, Mark
Schellings, Dirk
Van Gelder, Isabelle C.
Ruskin, Jeremy N.
Kowey, Peter R.
Dufton, Christopher
Maupas, Jean
Belardinelli, Luiz
CIRCULATION, 2022, 146
[5] Intravenous vernakalant in comparison with intravenous flecainide in the cardioversion of recent-onset atrial fibrillation
Pohjantahti-Maaroos, Hanna
Hyppola, Harri
Lekkala, Maria
Sinisalo, Emma
Heikkola, Antti
Hartikainen, Juha
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2019, 8 (02) : 114 - 120
[6] Cardioversion of recent-onset paroxysmal atrial fibrillation to sinus rhythm in the emergency department: Comparison of intravenous drugs
Amatucci, G
De Luca, G
Palazzuoli, A
Signorini, I
Bova, G
Auteri, A
Verzuri, MS
NEW ADVANCES IN HEART FAILURE AND ATRIAL FIBRILLATION, 2003, : 317 - 320
[7] Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation
Khan, IA
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 87 (2-3) : 121 - 128
[8] CARDIOVERSION OF ATRIAL-FIBRILLATION OF RECENT ONSET WITH FLECAINIDE
CARR, B
HAWLEY, K
CHANNER, KS
POSTGRADUATE MEDICAL JOURNAL, 1991, 67 (789) : 659 - 662
[9] Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm INSTANT Phase 2 Trial
Ruskin, Jeremy N.
Camm, John
Dufton, Christopher
Woite-Silva, Anderson C.
Tuininga, Ype
Badings, Erik
De Jong, Jonas S. S. G.
Oosterhof, Thomas
Aksoy, Ismail
Kuijper, Aaf F. M.
Van Gelder, Isabelle C.
van Dijk, Vincent
Nuyens, Dieter
Schellings, Dirk
Lee, Mark Young
Kowey, Peter R.
Crijns, Harry J. G. M.
Maupas, Jean
Belardinelli, Luiz
JACC-CLINICAL ELECTROPHYSIOLOGY, 2024, 10 (06) : 1021 - 1033
[10] Cardioversion in atrial fibrillation. Focus on recent-onset atrial fibrillation
Tampieri, Andrea
Rusconi, Anna Maria
Lenzi, Tiziano
INTERNAL AND EMERGENCY MEDICINE, 2012, 7 : S241 - S250

← 1 2 3 4 5 →